Publications by authors named "D Gregson"

Objectives: We evaluated the costs of susceptible and resistant bloodstream infections (BSIs) in adults. Secondary outcomes were the impact of BSI on length of stay (LOS), readmissions and death.

Methods: We examined a population-based retrospective cohort of blood cultures from 2011 to 2018 in Calgary, Canada, linked to microcosting and gross costing data.

View Article and Find Full Text PDF

This multi-year study (2014-2019) compared identification of rare and unusual Gram-negative organisms (GNOs) by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (VITEK MS, bioMérieux, Laval Que.) to 16S rRNA gene sequencing (16S) according to our laboratories routine workflow; 16S is done if initial MALDI-TOF MS gave discordant, wrong, or no results. GNB isolates were first analyzed by standard phenotypic methods and MALDI-TOF MS using direct deposit-full formic acid extraction; proteomics was repeated if no result occurred.

View Article and Find Full Text PDF

is the most prevalent cystic fibrosis (CF) pathogen. Several phenotypes are associated with worsened CF clinical outcomes including methicillin-resistance and small-colony-variants. The inoculum effect (IE) is characterized by reduced β-lactam susceptibility when assessed at high inoculum.

View Article and Find Full Text PDF

We examined the effect of an antimicrobial stewardship program (ASP), procalcitonin testing and rapid blood-culture identification on hospital mortality in a prospective quality improvement project in critically ill septic adults. Secondarily, we have reported antimicrobial guideline concordance, acceptance of ASP interventions, and antimicrobial and health-resource utilization.

View Article and Find Full Text PDF
Article Synopsis
  • The study addresses the uncertainty regarding the best treatment for penicillin-susceptible Staphylococcus aureus (PSSA) infections and concerns about testing reliability for detecting some resistant strains.
  • Researchers sent PSSA isolates to 34 labs across multiple countries to evaluate the performance of two different susceptibility testing methods (CLSI and EUCAST) using blaZ PCR as a reference.
  • Results showed that the EUCAST method had better accuracy and lower error rates compared to the CLSI method, highlighting the need to consider that most clinically relevant PSSA isolates do not have genetic elements indicating resistance, making treatment decisions complex.
View Article and Find Full Text PDF